Science Explorer Interactive view Map
Research facility · Calgary · Canada

Institute of Cancer Research

In research, Institute of Cancer Research stands highest in Medicine (#2,908 of 17,978 worldwide), Life Sciences (#2,500 of 14,347 worldwide) and Health Sciences (#3,873 of 20,462 worldwide), over all time.

cihr-irsc.gc.ca/e/12506.htmlROR OpenAlex
World rank, 2022–2025
#13,765
of 28,054 · #4,889 all time
Rank in Canada
#218
of 403
Research works
851
▼ 8% vs 2013–17
Citations
36k
42.0 per fractional work
Top-10% rate
17.4%
record average 16.5%
Open access
41%
world 28%

What is Institute of Cancer Research known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #2,908 of 17,978 27.0%395
Life SciencesDomain #2,500 of 14,347 30.2%336
Health SciencesDomain #3,873 of 20,462 27.1%413
Biochemistry, Genetics and Molecular BiologyField #2,474 of 7,814 29.7%246
Molecular BiologySubfield #1,893 of 4,961 30.5%150

Each strip is that field’s whole ranked pool, with the notch where Institute of Cancer Research sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.13× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.34× its world share, 26 worksBiochemistry, Geneti…Immunology and Microbiology: 5.28× its world share, 5 worksImmunology and Micro…Neuroscience: 0.71× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.36× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.11× its world share, 0 worksChemical EngineeringChemistry: 0.60× its world share, 1 worksChemistryComputer Science: 0.08× its world share, 1 worksComputer ScienceEngineering: 0.19× its world share, 3 worksEngineeringEnvironmental Science: 0.08× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.06× its world share, 0 worksMaterials ScienceMathematics: 0.41× its world share, 0 worksMathematicsPhysics and Astronomy: 0.50× its world share, 1 worksPhysics and AstronomyDentistry: 0.33× its world share, 0 worksDentistryHealth Professions: 0.30× its world share, 1 worksHealth ProfessionsMedicine: 2.81× its world share, 50 worksMedicineNursing: 0.18× its world share, 0 worksNursingBusiness, Management and Accounting: 0.03× its world share, 0 worksBusiness, Management…Decision Sciences: 0.12× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.27× its world share, 0 worksEconomics, Econometr…Psychology: 0.27× its world share, 1 worksPsychologySocial Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.3×. Every wedge is a field page.

Who are the top researchers at Institute of Cancer Research?

Ranked on the composite score, E. L. Kennaway lead among researchers whose main affiliation is Institute of Cancer Research.

  1. 1 E. L. Kennaway Canada · #210,419 worldwide 92 citations · 22 works
All ranked researchers at Institute of Cancer Research

Which keywords describe research at Institute of Cancer Research?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Cancer, Cancer Therapy, Radiotherapy, Tumor Microenvironment, Minimal Residual Disease and Proteasome Inhibitors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy8▲ 11×14 topics
  2. Cancer7▲ 5.5×27 topics
  3. Chemotherapy6▲ 9.7×17 topics
  4. Cancer Therapy5▲ 10×13 topics
  5. Radiotherapy5▲ 15×10 topics
  6. Tumor Microenvironment5▲ 12×8 topics
  7. Minimal Residual Disease5▲ 76×2 topics
  8. Prognostic Factors5▲ 12×11 topics
  9. Proteasome Inhibitors5▲ 74×2 topics
  10. Staging System4▲ 77×2 topics
  11. Diagnosis Criteria4▲ 130×1 topic
  12. International Myeloma Working Group4▲ 130×1 topic
  13. Cancer Immunotherapy4▲ 29×3 topics
  14. Targeted Therapy4▲ 17×5 topics
  15. Lymphoma3▲ 22×4 topics
  16. Tumor Regression3▲ 32×2 topics
  17. Genomic Instability3▲ 30×3 topics
  18. Immune Response3▲ 5.8×12 topics
  19. Clinical Practice Guidelines3▲ 5.9×9 topics
  20. Transcriptional Regulation3▲ 20×5 topics
  21. Breast Cancer3▲ 13×8 topics
  22. Gene Expression3▲ 4.9×9 topics
  23. Innate Immunity3▲ 9.6×6 topics
  24. Leukemia3▲ 35×2 topics
  25. CAR T Cells3▲ 39×1 topic
  26. Chimeric Antigen Receptor3▲ 39×1 topic
  27. Precision Medicine3▲ 6.2×8 topics
  28. Synthetic Lethality3▲ 87×2 topics
  29. Homologous Recombination2▲ 60×2 topics
  30. Cell Death2▲ 11×6 topics
  31. Immunity2▲ 5.8×7 topics
  32. Immune Checkpoint Blockade2▲ 21×1 topic
  33. PD-1 and PD-L12▲ 21×1 topic
  34. Survival Analysis2▲ 8.2×5 topics
  35. Cancer Genomics2▲ 30×1 topic
  36. Epigenetics2▲ 51×3 topics
  37. Mutational Signatures2▲ 30×1 topic
  38. BET Bromodomains2▲ 72×1 topic
  39. Genetic Variants2▲ 12×5 topics
  40. PROTACs2▲ 72×1 topic

Which research topics does Institute of Cancer Research publish most on?

By volume in 2022–2025: Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and Cancer Genomics and Diagnostics.

Multiple Myeloma Researc…4Multiple Myeloma Research and Treatments: 4 fractional worksCAR-T cell therapy research: 3 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksCancer Genomics and Diag…2Cancer Genomics and Diagnostics: 2 fractional worksProtein Degradation and Inhibitors: 2 fractional worksPARP inhibition in cancer therapy: 2 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksAcute Myeloid Leukemia Research: 1 fractional worksGlioma Diagnosis and Treatment: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional works
HematologyOncologyCancer ResearchMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Multiple Myeloma Research and Treatments Hematology 4 works
  2. 2 CAR-T cell therapy research Oncology 3 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 2 works
  5. 5 Protein Degradation and Inhibitors Molecular Biology 2 works
  6. 6 PARP inhibition in cancer therapy Oncology 2 works
  7. 7 Immunotherapy and Immune Responses Immunology 1 works
  8. 8 Acute Myeloid Leukemia Research Hematology 1 works
  9. 9 Glioma Diagnosis and Treatment Genetics 1 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.0%not open59.0%

World: 28% of research is openly available.

with international co-authors55.6%domestic only44.4%

World: 19% is written across borders.

How has Institute of Cancer Research's research output changed?

Output in 2018–2022 was 8% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Calgary

All research institutions in Calgary

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.